APA (7th ed.) Citation

L, B., D, B., E, T., M, M., R, P., R, R., . . . C, A. (2014). Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: Results from the observational retrospective-prospective RUBINO study. Reumatismo, 66(3), 224. https://doi.org/10.4081/reumatismo.2014.748

Chicago Style (17th ed.) Citation

L, Bazzichi, et al. "Safety of Rituximab in the Routine Treatment of Rheumatoid Arthritis in Italy in Patients Refractory to Anti-TNFa Drugs: Results from the Observational Retrospective-prospective RUBINO Study." Reumatismo 66, no. 3 (2014): 224. https://doi.org/10.4081/reumatismo.2014.748.

MLA (9th ed.) Citation

L, Bazzichi, et al. "Safety of Rituximab in the Routine Treatment of Rheumatoid Arthritis in Italy in Patients Refractory to Anti-TNFa Drugs: Results from the Observational Retrospective-prospective RUBINO Study." Reumatismo, vol. 66, no. 3, 2014, p. 224, https://doi.org/10.4081/reumatismo.2014.748.